Beijing BIOOCUS Biotech Ltd. is proud to present its revolutionary Adoptive Cell Transfer Therapy with Tumor-Infiltrating Lymphocytes. This cutting-edge therapy utilizes a patient's own immune cells, known as tumor-infiltrating lymphocytes (TILs), to target and destroy cancer cells. The process begins with the extraction of TILs from the patient's tumor, which are then isolated, multiplied, and activated in our state-of-the-art laboratory. Once the TILs have been expanded to sufficient numbers, they are infused back into the patient where they can recognize and attack the cancerous cells
Please feel free to give your inquiry in the form below We will reply you in 24 hours